Switching first-line disease-modifying therapy for relapsing-remitting multiple sclerosis in non-responders: is it a successful strategy?

被引：0
|
作者：
Gajofatto, A. [1 ]
Bacchetti, P. [1 ]
Grimes, B. [1 ]
High, A. [1 ]
Moraes, C. [1 ]
Waubant, E. [1 ]
机构：
[1] Univ Calif San Diego, San Francisco, CA USA
来源：
MULTIPLE SCLEROSIS | 2007年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S45 / S45
页数：1
相关论文
共 50 条
  • [21] Pregnancy and disease-modifying therapies in patients with relapsing-remitting multiple sclerosis
    Oztekin, N. S.
    Oztekin, M. F.
    MULTIPLE SCLEROSIS, 2006, 12 : S95 - S96
  • [22] Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis
    Roos, Izanne
    Malpas, Charles
    Leray, Emmanuelle
    Casey, Romain
    Horakova, Dana
    Havrdova, Eva Kubala
    Debouverie, Marc
    Patti, Francesco
    De Seze, Jerome
    Izquierdo, Guillermo
    Eichau, Sara
    Edan, Gilles
    Prat, Alexandre
    Girard, Marc
    Ozakbas, Serkan
    Grammond, Pierre
    Zephir, Helene
    Ciron, Jonathan
    Maillart, Elisabeth
    Moreau, Thibault
    Amato, Maria Pia
    Labauge, Pierre
    Alroughani, Raed
    Buzzard, Katherine
    Skibina, Olga
    Terzi, Murat
    Laplaud, David Axel
    Berger, Eric
    Grand'Maison, Francois
    Lebrun-Frenay, Christine
    Cartechini, Elisabetta
    Boz, Cavit
    Lechner-Scott, Jeannette
    Clavelou, Pierre
    Stankoff, Bruno
    Prevost, Julie
    Kappos, Ludwig
    Pelletier, Jean
    Shaygannejad, Vahid
    Yamout, Bassem, I
    Khoury, Samia J.
    Gerlach, Oliver
    Spitaleri, Daniele L. A.
    Van Pesch, Vincent
    Gout, Olivier
    Turkoglu, Recai
    Heinzlef, Olivier
    Thouvenot, Eric
    McCombe, Pamela Ann
    Soysal, Aysun
    NEUROLOGY, 2022, 99 (17) : E1926 - E1944
  • [23] Changing disease modifying therapy switching dynamics for relapsing-remitting multiple sclerosis patients
    Wakeford, C.
    Ye, X.
    Pike, J.
    Jones, E.
    Hadfield, A.
    Fam, S.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 330 - 330
  • [24] A Real-World Experience of Azathioprine Versus First-Line Disease-Modifying Therapy in Relapsing-Remitting Multiple Sclerosis-A Prospective Cohort Study
    Agrawal, Arpit
    Srivastava, M. V. Padma
    Bhatia, Rohit
    Goyal, Vinay
    Singh, Mamta Bhushan
    Vishnu, Venugopalan Y.
    Prabhakar, Anuj
    BRAIN SCIENCES, 2023, 13 (09)
  • [25] Impact of switching first-line disease-modifying therapy (f1DMT) after failure in relapsing-remitting (RR) MS
    Gajofatto, Alberto
    High, Andrew
    Waubant, Emmanuelle
    ANNALS OF NEUROLOGY, 2007, 62 : S69 - S70
  • [26] First-line therapy in relapsing remitting multiple sclerosis
    Biotti, D.
    Ciron, J.
    REVUE NEUROLOGIQUE, 2018, 174 (06) : 419 - 428
  • [27] Discontinuation of first-line disease-modifying therapy in multiple sclerosis
    Coerver, E. M.
    Bourass, A.
    Wessels, M. H.
    Van Kempen, Z. L.
    Jasperse, B.
    Barkhof, F.
    Mostert, J.
    Uitdehaag, B. M.
    Killestein, J.
    Strijbis, E. M.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 338 - 338
  • [28] Disease-modifying drugs for relapsing-remitting multiple sclerosis and future directions for multiple sclerosis therapeutics
    Rudick, RA
    ARCHIVES OF NEUROLOGY, 1999, 56 (09) : 1079 - 1084
  • [29] Effect of Disease-Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years
    Kalincik, Tomas
    Diouf, Ibrahima
    Sharmin, Sifat
    Malpas, Charles
    Spelman, Tim
    Horakova, Dana
    Havrdova, Eva Kubala
    Trojano, Maria
    Izquierdo, Guillermo
    Lugaresi, Alessandra
    Prat, Alexandre
    Girard, Marc
    Duquette, Pierre
    Grammond, Pierre
    Jokubaitis, Vilija
    Van der Walt, Anneke
    Grand'Maison, Francois
    Sola, Patrizia
    Ferraro, Diana
    Shaygannejad, Vahid
    Alroughani, Raed
    Hupperts, Raymond
    Terzi, Murat
    Boz, Cavit
    Lechner-Scott, Jeannette
    Pucci, Eugenio
    Van Pesch, Vincent
    Granella, Franco
    Bergamaschi, Roberto
    Spitaleri, Daniele
    Slee, Mark
    Vucic, Steve
    Ampapa, Radek
    McCombe, Pamela
    Ramo-Tello, Cristina
    Prevost, Julie
    Olascoaga, Javier
    Cristiano, Edgardo
    Barnett, Michael
    Saladino, Maria Laura
    Sanchez-Menoyo, Jose Luis
    Hodgkinson, Suzanne
    Rozsa, Csilla
    Hughes, Stella
    Moore, Fraser
    Shaw, Cameron
    Butler, Ernest
    Skibina, Olga
    Gray, Orla
    Kermode, Allan
    NEUROLOGY, 2021, 96 (05) : E783 - E797
  • [30] The prevalence and characteristics of epilepsy in patients with relapsing-remitting multiple sclerosis treated with disease-modifying therapy
    Kolcava, J.
    Kocica, J.
    Stourac, P.
    Bednarik, J.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2020, 83 (04) : 424 - 427
12345